Thalwieser, Zs., Fonódi, M., Király, N., Csortos, Cs., Boratkó, A.: PP2A affects angiogenesis via its interaction with a novel phosphorylation site of TSP1. International Journal of Molecular Sciences 25, 1844, pp. 1-23 (2024)
Tóth, E., Fagyas, M., Nagy, B., Mányiné Siket, I., Szőke, B., Mártha, L., Mahdi, M., Erdősi, G., Pólik, Zs., Kappelmayer, J., Papp, Z., Borbély, A., Szabó, T., Balla, J., Balla, Gy., Bácsi, A., Szekanecz, Z., Bai, P., Tóth, A.: Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients. GeroScience 46, 1561-1574 (2024)
Marvi, G., Zohar, P., Ujlaki, Gy., Tóth, M., Amsalu, H., Poliska, Sz., Tar, K.: Stable knockdown of Drp1 improves retinoic acid-BDNF-induced neuronal differentiation through global transcriptomic changes and results in reduced phosphorylation of ERK1/2 independently of DUSP1 and 6. Frontiers in Cell and Developmental Biology 12:1342741, pp 1-25 (2024) (-Cellular Biochemistry)
Lontay B.: Ünnepelt a Debreceni Egyetem Orvosi Vegytani Intézete: 70 éves Dombrádi Viktor és Erdődi Ferenc. Biokémia XLVIII. évfolyam, 1. szám, 96-100 (2024)
Sturniolo, I., Váróczy, Cs., Regdon, Zs., Mázló, A., Muzsai, Sz., Bácsi, A., Intili, G., Hegedűs, Cs., Boothby, M.R., Holechek, J., Ferraris, D., Schüler, H., Virág, L.: PARP14 contributes to the development of the tumor-associated macrophage phenotype. International Journal of Molecular Sciences 25(7), 3601, pp.1-21 (2024)
Homolya, L., Mathomes, R.T., Varga, L., Docsa, T., Juhász, L., Hayes, J.M., Somsák, L.: Synthesis, in silico and kinetics evaluation of N-(beta-D-glucopyranosyl)-2-arylimidazole-4(5)-carboxamides and N-(beta-D-glucopyranosyl)-4(5)-arylimidazole-2-carboxamides as glycogen phosphorylase inhibitors. International Journal of Molecular Sciences 2024 25(9), 4591, pp. 1-21 (2024)
Szántó, M., Yélamos, J., Bai, P.: Specific and shared biological functions of PARP2 – is PARP2 really a lil’ brother of PARP1? (review). Expert Reviews in Molecular Medicine 26, e13, pp.1-22 (2024)
Schwarcz, Sz., Kovács, P., Nyerges, P., Ujlaki, Gy., Sipos, A., Uray, K., Bai, P., Mikó, E.: The bacterial metabolite, lithocholic acid, has antineoplastic effects in pancreatic adenocarcinoma. Cell Death Discovery 10(1), 248 pp. 12 (2024)
Sturniolo, I., Váróczy, Cs., Bede, Á.M., Hegedűs, Cs., Demény M.Á., Virág, L.: Quantifying antibody-dependent cellular cytotoxicity in a tumor spheroid model: application for drug discovery. Journal of Visualized Experiments (JOVE) 206, e65922, pp 1-14 (2024)
Keller, I., Ungvári, Á., Kinter, R., Szalmás, F., Kókai, E., Lontay, B.: Smoothelin-like protein 1 promotes insulin sensitivity and modulates the contractile properties of endometrial epithelial cells with insulin resistance. Frontiers in Endocrinology-Cellular Endocrinology 15:1375771, pp 1-17 (2024)
Fonódi, M., Nagy, L., Boratkó, A.: Role of protein phosphatases in tumor angiogenesis: assessing PP1, PP2A, PP2B and PTPs activity. International Journal of Molecular Sciences 2024, 25, 6868, pp. 1-43 (2024) (review)
Schwarcz, Sz., Nyerges, P., Bíró, T.I., Janka, E., Bai, P., Mikó, E.: Cytostatic bacterial metabolites interfere with 5-fluorouracil, doxorubicin and paclitaxel efficiency in 4T1 breast cancer cells. Molecules 2024, 29, 3073, pp 1-16 (2024)
Szeőcs, D., Vida, B., Petővári, G., Póliska, Sz., Janka, E., Sipos, A., Uray, K., Sebestyén, A., Krasznai, Z., Bai, P.: Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGFbeta-ERK signalling. GeroScience 46, 3581-3597 (2024)
Marvi Ghani, Szabó, B., Alkhatibe, M., Amsalu, H., Zhar, P., Janka, E.A., Mógyán, J.A., Tar, K.: Serine 39 in the GTP-binding domain of Drp1 is involved in shaping mitochondrial morphology. FEBS OpenBio 14, 1147-1165 (2024)
Oit-Wiscombe, I., Virág, L., Kilk, K., Soomets, U., Altraja, A.: Pattern of expression of genes involved in systemic inflammation and glutathione metabolism reveals exacerbation of COPD. Antioxidants 2024, 13, 953, pp. 1-14 (2024)
Mikó, E., Sipos, A., Tóth, E., Lehoczki, A., Fekete, M., Sebő, É., Kardos, G., Bai, P.: Guideline for designing microbiome studies in neoplastic diseases. GeroScience 46, 4037-4057 (2024)
Papp, H.*, Tóth, E.*, Bóvári-Biri, J., Bánfai, K., Juhász, P., Mahdi, M., Russo, L.C., Bajusz, D., Sipos, A., Petri, L., Szalai, T.V., Kemény, Á., Madai, M., Kuczmog, A., Batta, Gy., Mózner, O., Vaskó, D., Hirsch, E., Bohus, P., Méhes, G., Tőzsér, J., Curtin, N.J., Helyes, Zs., Tóth, A., Hoch, N.C., Jakab, F., Keserű, Gy.M., Pongrácz, J.E., Bai, P.: The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19. British Journal of Pharmacology 181, 4782-4803 (2024) (megosztott első szerző: Papp, H., Tóth, E.
Márton, A., Veres, K.B., Erdődi, F., Udvardy, M., Illés, Á., Rejtő, L.: The roles of phosphorylation of signalling proteins in the prognosis of acute myeloid leukemia. Pathology and Oncology Research 30, pp. 1-18 (2024)
Máthé, Cs., Bóka, K., Kónya, Z., Erdődi, F., Vasas, G., Freytag, Cs., Garda, T.: Microcystin-LR, a cyanotoxin, modulates division of higher plant chloroplasts through protein phosphatase inhibition and affects cyanobacterial division. Chemosphere 358, pp. 1-11 (2024)
Kelemen, A., Garda, T., Kónya, Z., Erdődi, F., Ujlaki-Nagy, L., Juhász, G.P, Freytag, Cs., M-Hamvas, M., Máthé, Cs.: Treatments with diquat reveal the relationship between protein phosphatases (PP2A) and oxidative stress during mitosis in Arabidopsis thaliana root meristems. Plants-Basel 13(14), 1-16 (2024)
Köröskényi, K., Sós, L., Rostás, M., Papp, AB., Kókai, E., Garabuczi, É., Deák, D., Beke, L., Méhes, G., Szondy, Zs.: Loss of MER tyrosine kinase attenuates adipocyte hypertrophy and leads to enhanced thermogenesis in mice exposed to high-fat diet. Cells 13 (22), pp. 1-20 (2024)
Kovács, P.*, Schwarcz, Sz.*, Nyerges, P., Bíró, T.I., Ujlaki, Gy., Bai, P., Mikó, E.: Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models. Frontiers in Cell and Developmental Biology-Cancer Cell Biology 12:1487685, pp.1-14 (2024) (*megosztott első szerzők)
Kállai, J., Gindele, R., Pénzes-Daku, K., Balogh, G., Bogáti, R., Bécsi, B., Katona, É., Oláh, Zs., Ilonczai, P., Boda, Z., Róna-Tas, Á., Nemes, L., Marton, I., Bereczky, Zs.: Clinical and molecular characterization of nine novel antithrombin mutations. International Journal of Molecular Sciences 2024, 25, 2893. pp. 1-19 (2024)
Kolostyák, Z., Bojcsuk, D., Baksa, V., Máthéné Szigeti, Z., Bene, K,. Czimmerer, Z., Botó, P., Fadel, L., Póliska, S., Halász, L., Tzerpos, P., Berger, W., Villabona-Rueda, A., Varga, Z., Kovács, T., Patsalos, A., Pap, A., Vámosi, G., Bai, P., Dezső, B., Spite, M., D’Alessio, F., Szatmári, I., Nagy, L.: EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages. JCI Insight 2024, 9(17), e164009, pp. 1-22, (2024)